These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1631358)

  • 1. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Sneddon's syndrome.
    Mascarenhas R; Santo G; Gonçalo M; Ferro MA; Tellechea O; Figueiredo A
    Eur J Dermatol; 2003; 13(3):283-7. PubMed ID: 12804991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
    Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
    Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies.
    Kalashnikova LA; Nasonov EL; Borisenko VV; Usman VB; Prudnikova LZ; Kovaljov VU; Kushekbaeva AF
    Clin Exp Rheumatol; 1991; 9(4):357-61. PubMed ID: 1934683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sneddon syndrome].
    Berchtold B; Hunziker T; Zala L; Braathen LR
    Hautarzt; 1991 May; 42(5):328-30. PubMed ID: 1874623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sneddon syndrome].
    Richard MA; Grob JJ; Durand JM; Noë C; Basseres N; Bonerandi JJ
    Ann Dermatol Venereol; 1994; 121(4):331-7. PubMed ID: 7702255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Sneddon syndrome--diagnostic, etiological and therapeutic aspects].
    Aldenhövel HB
    Schweiz Rundsch Med Prax; 1990 Jun; 79(23):726-9. PubMed ID: 2195618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family.
    Lousa M; Sastre JL; Cancelas JA; Gobernado JM; Pardo A
    Stroke; 1994 May; 25(5):1071-4. PubMed ID: 8165682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sneddon syndrome: cardiac pathology and anti-phospholipid antibodies].
    Kalashnikova LA; Nasonov EL; Borisenko VV; Isman VB; Kushekbaeva AE; Kovalev VIu; Prudnikova LZ
    Klin Med (Mosk); 1990 Jun; 68(6):37-41. PubMed ID: 2214636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sneddon's syndrome with bilateral peripheral retinal neovascularization.
    Gobert A
    Bull Soc Belge Ophtalmol; 1995; 255():85-90. PubMed ID: 7496580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.